Point72 Asset Management
FENC icon

Point72 Asset Management’s Fennec Pharmaceuticals FENC Stock Holding History

Point72 Asset Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Buy
+56,407
New +$460K ﹤0.01% 3093
2026
Q1 		– Sell
-21,298
Closed -$164K – 4009
2025
Q4 		$164K Buy
+21,298
New +$175K ﹤0.01% 3678
2023
Q2 		– Sell
-3,100
Closed -$25.8K – 2366
2023
Q1 		$25.8K Buy
+3,100
New +$28.8K ﹤0.01% 1934

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Point72 Asset Management's FENC Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 56,407 shares worth $606K. The stake represents ﹤0.01% of the portfolio and ranks #3093 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in FENC as recently as Q4 2025.

Point72 Asset Management first reported a position in FENC in Q1 2023 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Point72 Asset Management held 56,407 shares of Fennec Pharmaceuticals worth $606K as of Q2 2026.
  • Fennec Pharmaceuticals was a new Point72 Asset Management position in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3093 holding.
  • Point72 Asset Management first reported a position in Fennec Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.